Environmental Effects of Inhaler Formulations
-
By
-
William B. Feldman
-
September 28, 2026
Original Source(s)
Related Content
FDA Expands CAPVAXIVE Pediatric Use
Phase 3 data showed noninferior immune responses vs pneumococcal 23-valent polysaccharide vaccine in pediatric patients at increased risk.
June 18, 2026
-
2 min
Does Sedative Choice Shape Later Cognition?
Researchers examined long-term cognitive outcomes among children who received ICU sedation for acute respiratory failure.
June 15, 2026
-
4 min
